Supplementation with placebo for 3-months had no observed significant changes or the opposite change of L-GSH supplementation for IL-6 and MDA
Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( c , e , g , l , n , p , v , x and z ) and two-way repeated measures ANOVA to assess main effects of treatment ( i , j , q , s and t )
Reactive oxygen species activate the Drosophila TNF receptor Wengen for damage-induced regeneration
Cognitive clarity becomes less consistent
[1] Commonly prescribed GLP-1 agonists include semaglutide (Ozempic for diabetes, Wegovy for weight management), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon)
Sonthalia, S., Daulatabad, D., & Sarkar, R